Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)
South Korea
· Delayed Price · Currency is KRW 6,060.00
+60.00 (1.00%)
At close: Mar 24, 2025, 3:30 PM KST
Jin Yang Pharmaceutical Revenue
In the year 2024, Jin Yang Pharmaceutical had annual revenue of 113.33B KRW with 20.94% growth. Jin Yang Pharmaceutical had revenue of 26.82B in the quarter ending December 31, 2024, with 10.67% growth.
Revenue
113.33B
Revenue Growth
+20.94%
P/S Ratio
0.57
Revenue / Employee
515.15M
Employees
220
Market Cap
69.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 113.33B | 19.62B | 20.94% |
| Dec 31, 2023 | 93.71B | 17.44B | 22.87% |
| Dec 31, 2022 | 76.26B | 13.43B | 21.36% |
| Dec 31, 2021 | 62.84B | 13.31B | 26.88% |
| Dec 31, 2020 | 49.52B | 2.17B | 4.59% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Kia Corporation | 107.45T |
| Celltrion | 3,557.30B |
| KB Financial Group | 15.01T |